Skip to main content
RLAY
NASDAQ Life Sciences

Relay Therapeutics Hits Phase 3 Milestone in X-Chem Collaboration

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.54
Mkt Cap
$4.063B
52W Low
$4.32
52W High
$21.27
52W Position info
329% above low
Off High info
13% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

RLAY has more than doubled off its 52-week low of $4.32 on light trading volume (0.3× avg).

Summary

Relay Therapeutics and X-Chem have reached a Phase 3 milestone in their collaboration, a positive development for the company's pipeline. This is the first report of this milestone, which could signal progress in a key program. The news follows a period of insider selling and an upsized ATM offering, but this milestone is a fresh, material update. Traders will want to understand the financial terms and which program advanced.

At the time of this announcement, RLAY was trading at $18.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1B. The 52-week trading range was $4.32 to $21.27. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

RLAY - Latest Insights

RLAY
Nov 04, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $18.02
Real-time Price: $16.19 info
Change: -$1.83 (-10%) info
Market Cap: $3.562B info
RLAY
Nov 04, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $18.02
Real-time Price: $16.19 info
Change: -$1.83 (-10%) info
Market Cap: $3.562B info
RLAY
Aug 25, 2026, 7:43 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $19.88
Real-time Price: $16.19 info
Change: -$3.69 (-19%) info
Market Cap: $3.562B info
RLAY
Aug 06, 2026, 4:41 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $19.30
Real-time Price: $16.19 info
Change: -$3.11 (-16%) info
Market Cap: $3.562B info
RLAY
Aug 06, 2026, 4:40 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $19.04
Real-time Price: $16.19 info
Change: -$2.85 (-15%) info
Market Cap: $3.562B info